BJP plotting to misuse EVMs alleges KPCC chief

Bengaluru, Jun 28: Novel coronavirus has claimed another police officer's life here, official sources said on Sunday.

According to official sources, the deceased police officer attached to station in Whitefield division had collapsed in his home on Saturday.

The 57-year-old Police officer, working as an Assistant Sub-Inspector (ASI) who was diagnosed with COVID-19 infection, also reportedly suffered from breathing related problems, the sources said.

Shivamogga, May 10: Karnataka Minister KS Eshwarappa on Sunday informed that eight people who returned to the state from Gujarat have tested positive for COVID-19 in Shivamogga district.

Shivamogga district is under the green zone category.

"Eight people who have returned from Ahmedabad, Gujarat have tested positive for COVID-19 in Shivamogga," said Eshwarappa.

Last week, the district administration had asked shopkeepers to open their shops on alternate days in order to avoid crowding.

According to the Ministry of Health and Family Welfare, the state has so far 794 confirmed COVID-19 cases which include 386 cured or discharged cases and 30 deaths.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.